Dr. Larry Corey receives public service award from American Society of Gene & Cell Therapy

Sonia Skarlatos Public Service Award recognizes person who has advanced field of gene and cell therapy
photo of Dr. Larry Corey standing in a courtyard
Dr. Larry Corey was honored by the American Society for Gene & Cell Therapy with its Sonia Skarlatos Public Service Award on May 13. Photo by Robert Hood / Fred Hutch News Service

Dr. Larry Corey of Fred Hutchinson Cancer Research Center is one of two winners of the American Society of Gene & Cell Therapy‘s Sonia Skarlatos Public Service Award. The award, named after a gene therapy advocate, recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education or nongovernmental charitable organizations.

Corey is an internationally renowned expert in virology, viral immunology and vaccine development. Most recently, he was asked to co-lead the COVID-19 Prevention Network vaccine program, which is responsible for implementing multiple COVID-19 vaccine efficacy trials in the U.S. and overseas. He is a past president and director of Fred Hutch, a professor in the Hutch’s Vaccine and Infectious Disease Division and a professor of medicine and laboratory medicine & pathology at the University of Washington. He was head of the UW Virology Division from 1978-2010 and led the AIDS Clinical Trials Group from 1987-1992. He has been the founder and principal investigator of the HIV Vaccine Trials Network since its inception in 1999.

Winners were chosen for four categories, from Outstanding New Investigator Award to Outstanding Achievement Award. The other recipient of the Sonia Skarlatos Public Service Award is Dr. Kathleen Neuzil, professor in the University of Maryland School of Medicine, who is part of the strategic team evaluating COVID-19 vaccines and therapeutics in the U.S. and was part of the study team who designed the first COVID-19 clinical vaccine trial in the U.S.

“While Kathy and I appreciate the personal selection of the award and have worked incredibly hard these last 13 months, so have hundreds, if not thousands, of other colleagues who worked side by side with us,” Corey said.

The award winners were acknowledged on May 13 at 12:15 p.m. EST virtually during the ASGCT annual meeting. Now in its 24th year, the ASGCT’s annual meeting brings together over 4,500 members in the United States and worldwide. Today, the ASGCT is the largest association of individuals involved in gene and cell therapy research.

— Adapted from an ASGCT announcement

Read more about Fred Hutch achievements and accolades.

Related News

All news
Dr. Hans-Peter Kiem elected vice president of American Society of Gene & Cell Therapy After serving 1 year as vice president, Kiem will serve as president-elect and president of the society May 4, 2020
5 reasons why a cancer research center has virology expertise Pathogens can cause diseases, the immune system can fight them March 18, 2021
Community engagement in HIV trials guides equity for COVID-19 vaccine studies New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines February 19, 2021

Help Us Eliminate Cancer

Every dollar counts. Please support lifesaving research today.